Surgery is a cornerstone intervention with all cancers and Gastric Cancers are no different. However, these types of cancers commonly go undetected in the early stage of disease progression which can prevent surgery even being a consideration in the treatment cascade. Surgical intervention is predominantly a priority in gastric cancer, with the aim being to remove the causative cancerous mass before it is able to grow and possibly metastasize to secondary sites around the body. However, surgery is a procedure prone to both clinical complications and to human error, which can lead to negative effects on patient outcomes.
Gastric Cancer progression, much like other cancers, is highly unpredictable. The metastatic spread can involve several sites with different tumor burdens. Therefore, planning the ideal sequence of intervention is still unclear and under debate. Also, the stomach has both a unique and vital role in the digestive system, so tumor resection surgery needs to be considerate to organ function and the potential long term impact on a patient's quality of life. As such, more still needs to be learned about optimizing the routes of surgical intervention, and also how to supplement these surgical interventions with complementary, adjuvant, or neoadjuvant therapy options.
This research topic is intended to put a focus on surgical interventions in gastric cancer diseases, and how this method of intervention can be revised, refined, and supplemented in order to improve patient outcomes and minimize risk of adverse effects during and after the procedures in question.
We welcome Original Research, leading-edge Reviews and Clinical Trials related but not limited to the aspects below:
- Laparoscopic surgical intervention in gastric cancer
- Prognostic impact of gastric surgeries
- Supplemental, adjuvant, or neoadjuvant therapies in pre/post surgical patients
- Surgical interventions in cancers metastatic to original gastric cancer
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Surgery is a cornerstone intervention with all cancers and Gastric Cancers are no different. However, these types of cancers commonly go undetected in the early stage of disease progression which can prevent surgery even being a consideration in the treatment cascade. Surgical intervention is predominantly a priority in gastric cancer, with the aim being to remove the causative cancerous mass before it is able to grow and possibly metastasize to secondary sites around the body. However, surgery is a procedure prone to both clinical complications and to human error, which can lead to negative effects on patient outcomes.
Gastric Cancer progression, much like other cancers, is highly unpredictable. The metastatic spread can involve several sites with different tumor burdens. Therefore, planning the ideal sequence of intervention is still unclear and under debate. Also, the stomach has both a unique and vital role in the digestive system, so tumor resection surgery needs to be considerate to organ function and the potential long term impact on a patient's quality of life. As such, more still needs to be learned about optimizing the routes of surgical intervention, and also how to supplement these surgical interventions with complementary, adjuvant, or neoadjuvant therapy options.
This research topic is intended to put a focus on surgical interventions in gastric cancer diseases, and how this method of intervention can be revised, refined, and supplemented in order to improve patient outcomes and minimize risk of adverse effects during and after the procedures in question.
We welcome Original Research, leading-edge Reviews and Clinical Trials related but not limited to the aspects below:
- Laparoscopic surgical intervention in gastric cancer
- Prognostic impact of gastric surgeries
- Supplemental, adjuvant, or neoadjuvant therapies in pre/post surgical patients
- Surgical interventions in cancers metastatic to original gastric cancer
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
